Recent developments in the treatment of bladder cancer

被引：0
作者：
Lance, RS [1 ]
Grossman, HB [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
来源：
BLADDER DISEASE: RESEARCH CONCEPTS AND CLINICAL APPLICATIONS, PTS A AND B | 2003年 / 539卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：3 / 14
页数：12
相关论文
共 60 条
[41]   Improved detection of recurrent bladder cancer using the Bard BTA stat Test [J].
Sarosdy, MF ;
Hudson, MA ;
Ellis, WJ ;
Soloway, MS ;
White, RD ;
Sheinfeld, J ;
Jarowenko, MV ;
Schellhammer, PF ;
Schervish, EW ;
Patel, JV ;
Chodak, GW ;
Lamm, DL ;
Johnson, RD ;
Henderson, M ;
Adams, G ;
Blumenstein, BA ;
Thoelke, KR ;
Pfalzgraf, RD ;
Murchison, HA ;
Brunelle, SL .
UROLOGY, 1997, 50 (03) :349-353
[42]   RESULTS OF A MULTICENTER TRIAL USING THE BTA TEST TO MONITOR FOR AND DIAGNOSE RECURRENT BLADDER-CANCER [J].
SAROSDY, MF ;
WHITE, RWD ;
SOLOWAY, MS ;
SHEINFELD, J ;
HUDSON, MA ;
SCHELLHAMMER, PF ;
JAROWENKO, MV ;
ADAMS, G ;
BLUMENSTEIN, BA .
JOURNAL OF UROLOGY, 1995, 154 (02) :379-383
[43]   CHROMOSOME-9 LOSS DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION IN BLADDER-CANCER [J].
SAUTER, G ;
MOCH, H ;
CARROLL, P ;
KERSCHMANN, R ;
MIHATSCH, MJ ;
WALDMAN, FM .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (02) :99-103
[44]  
SAUTER G, 1994, AM J PATHOL, V144, P756
[45]   A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer [J].
Schmetter, BS ;
Habicht, KK ;
Lamm, DL ;
Morales, A ;
Bander, NH ;
Grossman, HB ;
Hanna, MG ;
Silberman, SR ;
Butman, BT .
JOURNAL OF UROLOGY, 1997, 158 (03) :801-805
[46]   Interview with Patricia Viseur-Sellers, legal officer on gender issues [J].
Sharratt, S .
WOMEN & THERAPY, 1999, 22 (01) :53-78
[47]   Deoxyribonucleic acid ploidy enhances the cytological, prediction of recurrent transitional, cell carcinoma of the bladder [J].
Slaton, JW ;
Dinney, CPN ;
Veltri, RW ;
Miller, MC ;
Liebert, M ;
ODowd, GJ ;
Grossman, HB .
JOURNAL OF UROLOGY, 1997, 158 (03) :806-811
[48]   Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment [J].
Soloway, MS ;
Briggman, JV ;
Carpinito, GA ;
Chodak, GW ;
Church, PA ;
Lamm, DL ;
Lange, P ;
Messing, E ;
Pasciak, RM ;
Reservitz, GB ;
Rukstalis, DB ;
Sarosdy, MF ;
Stadler, WM ;
Thiel, RP ;
Hayden, CL .
JOURNAL OF UROLOGY, 1996, 156 (02) :363-367
[49]   Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer:: Short and long-term followup [J].
Solsona, E ;
Iborra, I ;
Ricós, JV ;
Monrós, JL ;
Casanova, J ;
Dumont, R .
JOURNAL OF UROLOGY, 1999, 161 (04) :1120-1123
[50]   Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder [J].
Stampfer, DS ;
Carpinito, GA ;
Rodriguez-Villanueva, J ;
Willsey, LW ;
Dinney, CP ;
Grossman, HB ;
Fritsche, HA ;
McDougal, WS .
JOURNAL OF UROLOGY, 1998, 159 (02) :394-398
123456